Loading...
Loading...
Biodel
BIOD dropped 16.10% to $4.22 after the company's BIOD-123 achieved primary endpoint in Phase 2 Clinical trial demonstrating glycemic control comparable to Humalog.
GW Pharmaceuticals plc
GWPH plummeted 13.60% to $14.17. GW Pharmaceuticals' trailing-twelve-month profit margin is -14.81%.
Orbital Corporation Limited
OBT dropped 8.64% to $2.75 after the company announced its plans to cancel United States based ADR program.
BioFuel Energy
BIOF dropped 7.59% to $3.91. BioFuel Energy's trailing-twelve-month ROE is -53.62%.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in